Comparison of two drugs nalbuphine and fentanyl as an additive to 0.5% hyperbaric bupivacaine in lower abdominal surgeries
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/08/056742
- Lead Sponsor
- SRI PRIYADHARSHINI BR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients posted for elective infra-umbilical surgerY under ASA physical status 1 & 2.
Exclusion Criteria
1. Body Mass Index >30.
2. Patients with local site infection, allergy to the drugs that are tested or any other contraindications for spinal anesthesia.
3. Patients who cannot lie down/ non co-operative/ psychiatric illness.
4. Alcoholics.
5. Pregnant / Lactating women.
6. Patient having failed spinal, transformed into general anesthesia will be excluded from study.
7. Patients refusal for participation in the study.
8. Patients with height less than 150 cm.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess and compare the duration of post operative analgesia of Nalbuphine and Fentanyl as an adjuvant to 0.5 % Hyperbaric bupivacaine as intrathecal anesthesia in infra-umbilical surgeries.Timepoint: Duration of post operative analgesia assessed for every 30 minutes for 4hours
- Secondary Outcome Measures
Name Time Method To assess and compare the onset and duration of sensory blockade and motor blockade. <br/ ><br>To assess and compare the hemodynamic parameters. <br/ ><br>To observe and compare the incidence of adverse events. <br/ ><br>Timepoint: 18 months